mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.01 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |